Since BTLA is highly expressed on B cells and global BTLA deletion was associated with enhanced auto-immune reactions in a number of studies [3,10,26,33], caution is warranted when envisioning anti-BTLA antibodies for the treatment of cancer in humans. This evidence concerns the gene BTLA and cancer.